| ACE | angiotensin-converting enzymes |
| ALM | appendicular lean mass |
| BALP | alkaline phosphatase bone |
| BIA | bioimpedance analysis |
| BMD | bone mass density |
| BMI | body mass index |
| CAD | coronary artery disease |
| COP | Circulating osteoprogenitor |
| CTX | C-terminal cross-linked telopeptide |
| DEXA | Dual-energy X-ray absorptiometry |
| EWGSOP2 | European Working Group on Sarcopenia in the Elderly |
| FDA | Food and Drug Administration |
| FFC | Falls and Fractures Clinic |
| FrOST | Franconian Osteopenia and Sarcopenia Trial |
| GH | the growth hormone |
| GMV | gluteus maximus muscle volume |
| HbA1c | glycated hemoglobin |
| Hb | hemoglobin |
| HIT-DRT | High-intensity dynamic resistance exercise |
| hpCRP | high-sensitivity C-reactive protein |
| HR | hazard ratio |
| GH | growth hormone |
| IGF-1; | insulin-like growth factor 1 |
| GH-IGF-1 axis | growth hormone-insulin-like growth factor 1 axis |
| IR | insulin resistance |
| MRI | Magnetic resonance imaging |
| MSCs | Mesenchymal stem cells |
| NCDs | Noncommunicable diseases |
| NOF | Nepean Osteoporosis and Frailty Study |
| OC | osteocalcin |
| OS | Osteosarcopenia; |
| PCOS | Polycystic ovary syndrome |
| PTH | parathyroid hormone |
| RANK-L | receptor activator of nuclear factor-kappa-β ligand |
| RCT | randomized controlled trials |
| RE | resistance exercise |
| SDI | Spine Deformity Index |
| SHBG | sex hormone-binding globulin |
| SMI | skeletal muscle index |
| SMD | standardized mean difference |
| SPPB | Short Physical Performance Battery |
| STS | sit-to-stand test |
| TBS | trabecular bone score |
| TD2M | Type 2 diabetes mellitus |
| TRAP | tartrate-resistant acid phosphatase |
| WPS | whey protein supplementation |